搜索到 1000 条关于 ȲݼӼ ryg622.top ߸2 ü ߸ϱ</span> <!-- ± --></xml></xmp><a href= 的文章
-
2013.04.13 英文写作常搞混的词汇
;number”用于可数名词，像是工作、样本、机器等。例句：I had a small number of specimens...彼此间并无法相互替代。2. Hypothesis vs Theory“
-
2012.09.19 2010年中、美临床和转化医学研究国际论坛
新药研发方向。论坛重点探讨1) 肿瘤; 2) 感染传染性疾病; 3) 心、脑血管疾病; 4) 内分泌代谢疾病; 5) 呼吸系统与环境卫生; 6) 神经系统疾病; 7... Pao, M.D.美国国立卫生研究院精神卫生研究所，临床研究主任。 NIMH, NIH。Dr. Julie A. Schneider
-
2013.03.13 The 2nd International Congress on Catalysis for Biorefineries
to attend the 2nd International Congress on Catalysis for Biorefineries (CatBior... from a petroleum-based to a bio-based industrial production. Integration
-
2013.07.03 BOA2013：MPDL3280A用于晚期和转移性NSCLC患者疗效与PD-L1表达状态相关
背景：人肺癌细胞表达高水平的PD-L1，抑制了抗肿瘤免疫反应。MPDL3280A是一种靶向PD-L1基因工程单克隆抗体，可抑 制其与受体PD-1的结合。通过置换 MPDL3280A第298位氨基酸，导致其非糖基化的重链形成，从而消除Fc段的生物学功能，这可能会降低毒性反应的发生和严重程度。另外
-
2012.09.27 2012年中美临床和转化医学国际论坛
分论坛A2代谢疾病转化医学...-17:30分论坛A1消化系统肿瘤的转化医学
-
2011.12.30 SCI论文写作常用经典句子
section, a short review of ... is given with special regard to ...l Section 2....l In Section 2 are presented the block diagram expression of a whole model
-
2012.09.19 第二届手性药物技术交流与成果应用研讨会
;二、会议内容 1、手性分子技术与手性药物及中间体研发进展；2、手性药物的质量控制及手性药物药学申报技巧... 1.本次会议将征集有关学术论文。会前将印刷论文集作为会议资料，统一为word文档（A4纸）,并将论文全文发至
-
2012.09.19 2011年生物仿制药会议（Biosimilars Asia 2011）
of biologics will lose patent protection by 2016, creating a significant market... is a risk-fraught activity that demands significant resources in R&D
-
-
2017.08.19 5 张图 Get 2017 阿维 A 治疗银屑病专家共识
、禁忌证、疗法、剂量、不良反应及对策等提出具体的建议。本文总结了 5 张图，一目了然掌握「共识」。1. 阿维 A 的药理特性2. 阿维 A 治疗机制3. 阿维...阿维 A（acitretin）自 1989 年上市以来，经近 30 年的临床应用，已证明在银屑病治疗中发挥了较重要的作用。目前仍然是是银屑病单一或联合疗法中
-
2012.08.09 2011年AHRQ成人2型糖尿病口服药治疗指南更新
Type 2 diabetes is a common chronic illness characterized by insulin... In addition, the death rate from cardiovascular disease in adults with type 2 diabetes
-
Background: Cabozantinib (Cabo) is an inhibitor of MET and VEGFR2. MET... over a 12 week (wk) lead-in stage. Response was assessed q6 wks. Treatment wk 12
-
-
2014.06.19 诺和诺德发布糖尿病复方药物IDegLira 3a期阳性试验结果
近日，诺和诺德2型糖尿病复方试验药物IDegLira的3期扩展试验获得积极试验结果。诺和诺德在美国糖尿病协会(ADA)年会上发布一项3a期试验结果，结果显示该公司每天注射一次的复方药物IDegLira（德谷胰岛素/利拉鲁肽）能使用药一年的2型糖尿病患者保持降糖效果，并证实其安全性。这项周期为26周的
-
-
2018.07.16 2
-
-
2016.10.20 2
-
2015.09.17 2
-
-
2020.01.08 公司2
公司2
-
-
2014.11.06 细胞-2
细胞-2
-
-
2014.11.06 Montreal 2
Montreal 2
-
2012.11.23 Rethinking HIV: After Five Years of Debate, a New Push for Prevention Read more: http
After decades of focusing almost exclusively on treating HIV, public health experts are now considering a new approach, moving to establish more effective prevention strategies to curb spread of the disease. Recent tests show that anti-HIV drugs that can hamper the growth of the virus responsible for AIDS may also prevent progression of the disease if given to infected individuals soon after their exposure to HIV. The same drugs can also prevent infections from taking hold among healthy people who are exposed to the virus; both approaches would be critical ways of controlling spread of the virus and keeping new cases of HIV to a minimum.\r\n\r\nRead more: http://healthland.time.com/2012/11/21/recommendations-for-routine-hiv-testing-represent-advances-in-preventing-hiv/#ixzz2CripWt9p